Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma
Article in Endocrine Metabolic & Immune Disorders - Drug Targets (January 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Endocrine Metabolic & Immune Disorders - Drug Targets (January 2023)
Article in Endocrine Metabolic & Immune Disorders - Drug Targets (January 2022)
Article in Current Cancer Therapy Reviews (April 2021)